保健品行业2025三季报总结：如期向好，个股分化

Investment Rating - The report maintains an "Accumulate" rating for the health supplement industry [1] Core Viewpoints - The health supplement sector showed positive growth in Q3 2025, with revenue and net profit increasing by 18% and 122% respectively, driven by low base effects [4][9] - The industry is undergoing a transformation with a shift towards online channels and new consumer demographics, indicating a promising outlook for growth [41][46] Summary by Sections 1. Q3 2025 Review: Stock Differentiation and Positive Operations - The health supplement sector's revenue and net profit growth reflects a recovery from low bases, with notable performances from companies like汤臣倍健 and民生健康 [4][9] -汤臣倍健 reported a Q3 revenue of 13.83 billion, up 23.45% year-on-year, marking a significant turnaround [10] -民生健康 achieved a revenue of 1.60 billion in Q3, a 30.84% increase year-on-year, indicating strong operational momentum [12] 2. Future Outlook: Focus on Quality Stocks with Valuation Space - The valuation of food additive companies is generally low, with many trading below the 50th percentile of historical PE ratios [32] - The report suggests focusing on quality leading companies that adapt to channel transformations and new consumer segments, such as H&H International Holdings and汤臣倍健 [31][56] 3. Health Supplement Industry: Strong Growth Potential - The health supplement market in China is projected to grow from 701.35 billion in 2010 to 2323.39 billion by 2024, with a CAGR of 8.93% [41] - The aging population and the rise of new consumption channels are expected to sustain growth, with an anticipated growth rate of over 6% from 2025 to 2027 [41][44] 4. Investment Recommendations: Focus on Quality Stocks - The report recommends focusing on brands with new channels and consumer logic, such as H&H International Holdings,民生健康, and汤臣倍健, which are expected to benefit from ongoing reforms and market dynamics [56]